Last 12 months
Inside the activity.
5 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 1 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 3 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2019 Filed Apr 12, 2019 18:20 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
SaleCommon Stock | 25,869 | $5.53 | $143,055.57 |
DisclosureSEC source: 0000899243-19-010612 · doc4.xml · nonDerivative · entry 2 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,349 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.66 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 12, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.66 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 12, 2019. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 18:20 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
SaleCommon Stock | 13,723 | $5.49 | $75,339.27 |
DisclosureSEC source: 0000899243-19-010612 · doc4.xml · nonDerivative · entry 1 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,218 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $5.53 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 11, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $5.53 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 11, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:33 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
GrantRestricted Stock Units · Derivative | 25,706 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-009842 · doc4.xml · derivative · entry 11 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,706 Underlying: Common Stock · 25,706 shares Expires not disclosed F3 · security: Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F5 · shares: On April 1, 2019, the Reporting Person was granted 25,706 RSUs, with 25% of such RSUs vesting on the first anniversary of the date of grant and the remainder vesting in equal quarterly installments over the succeeding three year period. F5 · derivative.expiration_date: On April 1, 2019, the Reporting Person was granted 25,706 RSUs, with 25% of such RSUs vesting on the first anniversary of the date of grant and the remainder vesting in equal quarterly installments over the succeeding three year period. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:33 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 106,112 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0000899243-19-009842 · doc4.xml · derivative · entry 10 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,112 Underlying: Common Stock · 106,112 shares Expires 2029-04-01 F4 · shares: On April 1, 2019, the Reporting Person was granted 106,112 options to purchase shares of Common Stock of the Issuer, with 25% of such options vesting on the first anniversary of the date of grant and the remainder vesting in equal quarterly installments over the succeeding three year period. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:33 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
SaleCommon Stock | 10,408 | $6.97 | $72,543.76 |
DisclosureSEC source: 0000899243-19-009842 · doc4.xml · nonDerivative · entry 1 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,941 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.55 to $7.08 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 1, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.55 to $7.08 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on April 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 17:15 UTC |
Amato Francis R.Director · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 74,404 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-009780 · doc4.xml · derivative · entry 2 Amato Francis R. · CIK 0001737615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,404 Underlying: Common Stock · 74,404 shares Expires not disclosed F2 · security: Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F3 · shares: On April 1, 2019, the Reporting Person was granted 74,404 RSUs under the Issuer's 2018 Omnibus Equity Incentive Plan, with 25% of such RSUs vesting on the first anniversary of the date of grant and the remainder vesting in equal quarterly installments over the succeeding three year period. F3 · derivative.expiration_date: On April 1, 2019, the Reporting Person was granted 74,404 RSUs under the Issuer's 2018 Omnibus Equity Incentive Plan, with 25% of such RSUs vesting on the first anniversary of the date of grant and the remainder vesting in equal quarterly installments over the succeeding three year period. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 17:15 UTC |
Amato Francis R.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 307,125 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0000899243-19-009780 · doc4.xml · derivative · entry 1 Amato Francis R. · CIK 0001737615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,125 Underlying: Common Stock · 307,125 shares Expires 2029-04-01 F1 · shares: On April 1, 2019, the Reporting Person was granted 307,125 options to purchase shares of Common Stock of the Issuer, with 25% of such options vesting on the first anniversary of the date of grant and the remainder vesting in equal quarterly installments over the succeeding three year period. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 21:48 UTC |
Staats Peter S.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 47,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0000899243-19-009476 · doc4.xml · derivative · entry 6 Staats Peter S. · CIK 0001737600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 47,000 shares Expires not disclosed F1 · date: On March 28, 2019, the Reporting Person was granted 8,976 shares of restricted stock and options to purchase 47,000 shares of Common Stock of the Issuer. 50% of the restricted stock and the options vest on December 31, 2019, and the remainder vests in equal annual installments over the succeeding two-year period F2 · derivative.expiration_date: The options have an expiration date one year after the termination or expiration of the Letter Agreement, dated as of March 28, 2019, between the Reporting Person and the Issuer. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 21:48 UTC |
Staats Peter S.Chief Medical Officer
|
GrantCommon Stock | 8,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-009476 · doc4.xml · nonDerivative · entry 1 Staats Peter S. · CIK 0001737600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,612 F1 · date: On March 28, 2019, the Reporting Person was granted 8,976 shares of restricted stock and options to purchase 47,000 shares of Common Stock of the Issuer. 50% of the restricted stock and the options vest on December 31, 2019, and the remainder vests in equal annual installments over the succeeding two-year period Read SEC document |
| March 22, 2019 Filed Mar 26, 2019 18:46 UTC |
Vraniak Glenn S.Chief Financial Officer
|
GrantStock Options · Derivative | 18,750 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0000899243-19-008974 · doc4.xml · derivative · entry 2 Vraniak Glenn S. · CIK 0001737660 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,685 Underlying: Common Stock · 18,750 shares Expires 2020-02-28 F1 · derivative.exercise_date: 100% of the restricted stock and the stock options vest on August 31, 2019, subject to the Reporting Person's compliance with the terms of the Separation and Release Agreement, dated March 22, 2019, between the Reporting Person and the Issuer. Read SEC document |
| March 22, 2019 Filed Mar 26, 2019 18:46 UTC |
Vraniak Glenn S.Chief Financial Officer
|
GrantRestricted Stock | 2,976 | $8.40 | $24,998.40 |
DisclosureSEC source: 0000899243-19-008974 · doc4.xml · nonDerivative · entry 1 Vraniak Glenn S. · CIK 0001737660 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,811 F1 · shares: 100% of the restricted stock and the stock options vest on August 31, 2019, subject to the Reporting Person's compliance with the terms of the Separation and Release Agreement, dated March 22, 2019, between the Reporting Person and the Issuer. Read SEC document |
| January 17, 2019 Filed Jan 17, 2019 20:36 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
SaleCommon Stock | 7,841 | $4.84 | $37,950.44 |
DisclosureSEC source: 0000899243-19-001414 · doc4.xml · nonDerivative · entry 3 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,349 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.95 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 17, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.95 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 17, 2019. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 20:36 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
SaleCommon Stock | 19,810 | $4.89 | $96,870.90 |
DisclosureSEC source: 0000899243-19-001414 · doc4.xml · nonDerivative · entry 2 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,190 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.81 to $4.97 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 16, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.81 to $4.97 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 16, 2019. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 20:36 UTC |
Errico Joseph PDirector · See Remarks · 10% owner
|
SaleCommon Stock | 22,349 | $4.90 | $109,510.10 |
DisclosureSEC source: 0000899243-19-001414 · doc4.xml · nonDerivative · entry 1 Errico Joseph P · CIK 0001737616 · Director · See Remarks · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,000 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $5.11 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $5.11 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 15, 2019. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 22:30 UTC |
Core Ventures II, LLC10% owner
|
OtherCommon Stock | 1,232,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-001229 · doc4.xml · nonDerivative · entry 1 Core Ventures II, LLC · CIK 0001571617 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500,649 F1 · kind: On January 11, 2019, the Reporting Person distributed an aggregate of 1,232,056 shares of Common Stock of the Issuer in a pro rata distribution to three members of the Reporting Person that are not affiliates of the Issuer. F1 · price: On January 11, 2019, the Reporting Person distributed an aggregate of 1,232,056 shares of Common Stock of the Issuer in a pro rata distribution to three members of the Reporting Person that are not affiliates of the Issuer. F1 · balance_after: On January 11, 2019, the Reporting Person distributed an aggregate of 1,232,056 shares of Common Stock of the Issuer in a pro rata distribution to three members of the Reporting Person that are not affiliates of the Issuer. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 11:10 UTC |
Staats Peter S.Chief Medical Officer
|
PurchaseCommon Stock | 10,000 | $4.83 | $48,300.00 |
DisclosureSEC source: 0001209191-18-062861 · doc4.xml · nonDerivative · entry 1 Staats Peter S. · CIK 0001737600 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,636 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.91 per share. The reporting person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on December 13, 2018. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 10:25 UTC |
Amato Francis R.Director · Chief Executive Officer
|
PurchaseCommon Stock | 7,500 | $6.53 | $49,008.75 |
DisclosureSEC source: 0001209191-18-061682 · doc4.xml · nonDerivative · entry 1 Amato Francis R. · CIK 0001737615 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,831 Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 16:35 UTC |
COX CARRIE SMITHDirector
|
PurchaseCommon Stock | 900 | $6.78 | $6,106.32 |
DisclosureSEC source: 0001209191-18-060719 · doc4.xml · nonDerivative · entry 2 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 16:35 UTC |
COX CARRIE SMITHDirector
|
PurchaseCommon Stock | 6,400 | $6.79 | $43,480.32 |
DisclosureSEC source: 0001209191-18-060719 · doc4.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 20:31 UTC |
COX CARRIE SMITHDirector
|
PurchaseCommon Stock | 3,700 | $13.76 | $50,919.40 |
DisclosureSEC source: 0001209191-18-047614 · doc4.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,033 Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 19:23 UTC | PurchaseCommon Stock | 166,666 | $15.00 | $2,499,990.00 |
DisclosureSEC source: 0001104659-18-041862 · a4.xml · nonDerivative · entry 1 Merck Global Health Innovation Fund, LLC · CIK 0001547132 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346,032 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.